About Mablink
Mablink is a company based in Lyon (France) founded in 2018 by Charles Dumontet, Warren Viricel, Benoit Joseph, and Jean Guillaume Lafay was acquired by Lilly in October 2023.. Mablink has raised $35 million across 3 funding rounds from investors including Lilly, Crédit Agricole and Elaia. Mablink operates in a competitive market with competitors including BeiGene, Moderna, GSK, Incyte and Avidity Biosciences, among others.
- Headquarter Lyon, France
- Founders Charles Dumontet, Warren Viricel, Benoit Joseph, Jean Guillaume Lafay
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Mablink
Mablink has successfully raised a total of $35M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $30.17 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $30.2M
-
First Round
First Round
(01 Jun 2018)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series A - Mablink | Valuation | Sofinnova Partners , Merieux Equity Partners | |
| Apr, 2021 | Amount | Seed - Mablink | Valuation | Elaia | |
| Jun, 2018 | Amount | Grant - Mablink | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mablink
Mablink has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Crédit Agricole and Elaia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on early-stage investments
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Cancer research is supported through funding and entrepreneurial guidance.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mablink
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mablink
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mablink Comparisons
Competitors of Mablink
Mablink operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, GSK, Incyte and Avidity Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mablink
Frequently Asked Questions about Mablink
When was Mablink founded?
Mablink was founded in 2018.
Where is Mablink located?
Mablink is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Is Mablink a funded company?
Mablink is a funded company, having raised a total of $35M across 3 funding rounds to date. The company's 1st funding round was a Grant of $1.72M, raised on Jun 01, 2018.
What does Mablink do?
Mablink was established in 2018 in Lyon, France, within the biotechnology sector. Antibody-drug conjugates for oncology applications are developed using a proprietary hydrophilic linker platform. This platform incorporates a non-polymeric 2.0 kDa linker that maintains plasma stability in homogeneous ADCs, without reliance on site-specific conjugation. Targeted products include MBK-101 and MBK-102, addressing acute myeloid leukemia and multiple myeloma.
Who are the top competitors of Mablink?
Mablink's top competitors include Moderna, BeiGene and Strand Therapeutics.
Who are Mablink's investors?
Mablink has 10 investors. Key investors include Lilly, Crédit Agricole, Elaia, Pertinence Invest, and Foundation Fournier-Majoie.